Location History:
- New Caney, TX (US) (2001)
- Philadelphia, PA (US) (2016 - 2024)
Company Filing History:
Years Active: 2001-2024
Title: Janice L Walker: Innovator in Epigenetic Research
Introduction
Janice L Walker is a prominent inventor based in Philadelphia, PA, known for her significant contributions to the field of epigenetics. With a total of four patents to her name, she has made remarkable strides in therapeutic treatments aimed at preventing fibrosis.
Latest Patents
Among her latest patents is a groundbreaking therapeutic treatment that focuses on drug-induced epigenetic remodeling to prevent fibrosis. This innovative approach involves administering a UTX or JMJD3 inhibitor to patients, which has proven effective in preventing or reducing fibrosis, particularly in cases where access to injured or dysmorphogenetic tissues is critical before the fibrotic process becomes established.
Career Highlights
Janice has worked with Thomas Jefferson University, where she has been able to apply her research in a practical setting. Her work has garnered attention for its potential to change the landscape of treatment for fibrotic conditions.
Collaborations
Throughout her career, Janice has collaborated with notable colleagues, including Alexander Mazo and Svetlana Petruk, contributing to a rich exchange of ideas and advancements in their field.
Conclusion
Janice L Walker's innovative work in epigenetic research and her dedication to developing effective treatments for fibrosis highlight her importance as an inventor. Her contributions continue to pave the way for future advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.